Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NEUROCATH AG

K-Number: K081942 · 2008-08-12

ApplicantVygon Neuro
Decision Date2008-08-12
Product CodeJXG
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

NEUROCATH AG is the device name listed in this FDA 510(k) record. The listed applicant is Vygon Neuro. It received FDA 510(k) clearance on 2008-08-12 under 510(k) number K081942. The device is classified under product code JXG. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NEUROCATH AG?

NEUROCATH AG is a medical device that received FDA 510(k) clearance on 2008-08-12. The listed applicant is Vygon Neuro. The 510(k) number is K081942.

When did NEUROCATH AG receive FDA 510(k) clearance?

NEUROCATH AG received FDA 510(k) clearance on 2008-08-12, under 510(k) number K081942.

Who is the listed applicant for NEUROCATH AG?

The FDA 510(k) record lists Vygon Neuro as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NEUROCATH AG?

The FDA product code for NEUROCATH AG is JXG.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: JXG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑